Association of Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients

Arthritis Care and Research

Volumn 69, Issue 7, 2017, Pages 1088-1094

  Kishi, Takayuki ^a   Rider, Lisa G ^a   Pak, Katherine ^b   Barillas Arias, Lilliana ^c   Henrickson, Michael ^d   McCarthy, Paul L ^e   Shaham, Bracha ^f   Weiss, Pamela F ^g   Horkayne Szakaly, Iren ^h   Targoff, Ira N ⁱ   Miller, Frederick W ^a   Mammen, Andrew L ^b   Abramson, Leslie S ^j   Albert, Daniel A ^j   Baer, Alan N ^j   Balboni, Imelda M ^j   Ballinger, Susan ^j   Becker, Mara ^j   Bingham, C April ^j   Bohnsack, John F ^j   Botstein, Gary R ^j   Carrasco, Ruy ^j   Cartwright, Victoria W ^j   Chao, Chun Peng T ^j   Cron, Randy Q ^j   Curiel, Rodolfo ^j   DeGuzman, Marietta M ^j   De la Pena, Wendy ^j   Eberhard, B Anne ^j   Edelheit, Barbara S ^j   Ellsworth, Janet ^j   Finkel, Terri H ^j   Fuhlbrigge, Robert C ^j   Gabriel, Christos A ^j   Gedalia, Abraham ^j   Gewanter, Harry L ^j   Goldmuntz, Ellen A ^j   Goldsmith, Donald P ^j   Gottlieb, Beth S ^j   Graham, Brent ^j   Griffin, Thomas A ^j   Haftel, Hilary M ^j   Hannan, William ^j   Hennon, Teresa ^j   Hoeltzel, Mark F ^j   Hollister, J Roger ^j   Hopp, Russell J ^j   Imundo, Lisa F ^j   Jansen, Anna ^j   Jarvis, James ^j   Jerath, Rita S ^j   Johnson, Courtney R ^j   Jones, Olcay Y ^j   Jung, Lawrence K ^j   Kamdar, Ankur ^j   Katona, Ildy M ^j   Kim, Hanna ^j   Kim, Susan ^j   Kingsbury, Daniel J ^j   Klein, Steven J ^j   Lang, Bianca A ^j   Levine, Johanan ^j   Lindsley, Carol B ^j   Mamyrova, Gulnara ^j   Mitchell, Ray ^j   Morishima, Chihiro ^j   Moser, David W ^j   Murphy, Frederick T ^j   Myers, Linda K ^j   Nanda, Kabita ^j   Nativ, Simona ^j   Oral, Elif A ^j   Ostrov, Barbara E ^j   Pappu, Ramesh ^j   Parker, Christopher T ^j   Passo, Murray H ^j   Perez, Maria D ^j   Person, Donald A ^j   Punaro, Marilyn G ^j   Rabinovich, C Egla ^j   Rennebohm, Robert M ^j   Rivas Chacon, Rafael F ^j   Ronis, Tova ^j   Rosenkranz, Margalit ^j   Schiffenbauer, Adam ^j   Sheets, Robert M ^j   Sherry, David D ^j   Sills, Edward M ^j   Sinal, Sara H ^j   Stoll, Matthew ^j   Sule, Sangeeta D ^j   Sundel, Robert P ^j   Vehe, Richard K ^j   Vogelgesang, Scott A ^j   Wargula, Jennifer C ^j   Yung, Christine M ^j   Zemel, Lawrence S ^j   more..

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c ALBANY MEDICAL CENTER   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h Defense Health Agency   (United States)

ⁱ UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; ENZYME ANTIBODY; HLA DRB1 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; UNCLASSIFIED DRUG; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A; ACYL COENZYME A; AUTOANTIBODY; BIOLOGICAL MARKER; NERVE PROTEIN; RBM45 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADOLESCENT; ALLELE; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JOINT CONTRACTURE; JUVENILE MYOSITIS; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOSITIS; NECROTIZING MYOPATHY; PRESCHOOL CHILD; RASH; SCHOOL CHILD; TREATMENT RESPONSE; BLOOD; SEVERITY OF ILLNESS INDEX;

ACYL COENZYME A; ADOLESCENT; AUTOANTIBODIES; BIOMARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MYOSITIS; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 85021292049     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.23113     Document Type: Article

References (15)

1. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 2011;305:183–90.
2. Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 2008;47:324–8.
3. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713–21.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7.
5. Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, et al. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 2016;87:1038–44.
6. Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, et al. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve 2015;52:196–203.
7. Klein M, Mann H, Plestilova L, Zamecnik J, Betteridge Z, McHugh N, et al. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. Rheumatology (Oxford) 2015;54:2010–4.
8. Ge Y, Lu X, Peng Q, Shu X, Wang G. Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies. PLoS One 2015;10:e0141616.
9. Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 2014;93:150–7.
10. Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, et al. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013;92:25–41.
11. Habers GE, Huber AM, Mamyrova G, Targoff IN, O'Hanlon TP, Adams S, et al. Association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis. Arthritis Rheumatol 2016;68:761–8.
12. Mamyrova G, O'Hanlon TP, Monroe JB, Carrick DM, Malley JD, Adams S, et al. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum 2006;54:3979–87.
13. Mammen AL, Gaudet D, Brisson D, Christopher-Stine L, Lloyd TE, Leffell MS, et al. Increased frequency of DRB1*11:01 in anti–hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care Res (Hoboken) 2012;64:1233–7.
14. Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 2005;52:2607–15.
15. Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J, et al. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis 2015;10:61.